Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.21 | N/A | -3.67% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.21 | N/A | -3.67% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Overall, management expressed caution regarding market dynamics. They highlighted the importance of operational efficiency in the current environment.
Management acknowledged the challenging market conditions.
They emphasized a focus on cost management and efficiency.
No specific guidance was provided for future quarters.
The earnings report indicates that Prestige Consumer HE is facing challenges, as evidenced by the EPS miss. The stock reacted negatively, dropping 3.22% on the news. Investors may be concerned about the lack of guidance and the overall market conditions affecting the company's performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HUMANA INC
Feb 7, 2011